Verteporfin PDT for non-standard indications-a review of current literature

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 5, 2010, Pages 613-626

  Chan, Wai Man ^a   Lim, Tock Han ^b   Pece, Alfredo ^c   Silva, Rufino ^d   Yoshimura, Nagahisa ^e  

^a HK Sanatorium Hospital   (Hong Kong)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c Ospedale di Melegnano   (Italy)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioid streaks; Central serous chorioretinopathy; Choroidal haemangioma; Inflammatory CNV; Polypoidal choroidal vasculopathy; Verteporfin; Visudyne

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PLACEBO; TACROLIMUS; TRIAMCINOLONE; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; VERTEPORFIN;

ANGIOID STREAK; CENTRAL SEROUS RETINOPATHY; CHOROID DISEASE; CHOROIDAL HEMANGIOMA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EYE INFLAMMATION; HUMAN; MONOTHERAPY; MYOPIA; OCULAR HISTOPLASMOSIS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROGNOSIS; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN DISEASE; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOID STREAKS; CENTRAL SEROUS CHORIORETINOPATHY; CHOROID DISEASES; CHOROID NEOPLASMS; CHOROIDAL NEOVASCULARIZATION; HEMANGIOMA; HUMANS; PERIPHERAL VASCULAR DISEASES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL DISEASES;

EID: 77952089742     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1307-z     Document Type: Review

References (99)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP Report 2 Arch Ophthalmol 119 198 207
2. Verteporfin In Photodynamic Therapy (VIP) Study Group 2003 Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 3 Ophthalmology 110 667 673 10.1016/S0161-6420(02)01998-X (Pubitemid 36520061)
3. RA Costa EV Navajas ME Farah D Calucci JA Cardillo IU Scott 2005 Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm Prog Retin Eye Res 24 560 586 10.1016/j.preteyeres.2005.01.001 16005406 (Pubitemid 40943662)
4. M Uyama M Wada Y Nagai T Matsubara H Matsunaga I Fukushima K Takahashi M Matsumura 2002 Polypoidal choroidal vasculopathy: natural history Am J Ophthalmol 133 639 648 10.1016/S0002-9394(02)01404-6 11992861 (Pubitemid 34462012)
5. K Sho K Takahashi H Yamada M Wada Y Nagai T Otsuji M Nishikawa Y Mitsuma Y Yamazaki M Matsumura M Uyama 2003 Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392 1396 10.1001/archopht.121.10.1392 14557174 (Pubitemid 37243739)
6. F Gomi M Ohji K Sayanagi M Sawa H Sakaguchi Y Oshima Y Ikuno Y Tano 2008 One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 141 146 10.1016/j.ophtha.2007.02.031 17582498 (Pubitemid 350309415)
7. I Maruko T Iida M Saito D Nagayama K Saito 2007 Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 15 22 10.1016/j.ajo.2007.03.047 17509509 (Pubitemid 46963198)
8. AP Ciardella IM Donsoff SJ Huang DL Costa LA Yannuzzi 2004 Polypoidal choroidal vasculopathy Surv Ophthalmol 49 25 37 10.1016/j.survophthal.2003.10. 007 14711438 (Pubitemid 38056622)
9. E Akaza M Yuzawa Y Matsumoto S Kashiwakura K Fujita R Mori 2007 Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270 277 10.1007/s10384-007-0452-3 17660987 (Pubitemid 47174610)
10. E Akaza R Mori M Yuzawa 2008 Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 717 722 10.1097/IAE. 0b013e31816577cb 18463515 (Pubitemid 351655124)
11. WM Chan DS Lam TY Lai DT Liu KK Li Y Yao TH Wong 2004 Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 1576 1584 10.1016/j.ophtha.2003.12.056 15288991 (Pubitemid 39030815)
12. M Cho IA Barbazetto KB Freund 2009 Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 148 70 78 10.1016/j.ajo.2009.02.012 19403115
13. Y Kurashige A Otani M Sasahara Y Yodoi H Tamura A Tsujikawa N Yoshimura 2008 Two-year results of photodynamic therapy for polypoidal choroidal vasculopathyy Am J Ophthalmol 146 513 519 10.1016/j.ajo.2008.05.025 18614133
14. MW Lee I Yeo D Wong CL Ang 2008 Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy Eye 23 1417 1422 10.1038/eye.2008.265 18756283
15. SC Lee YS Seong SS Kim HJ Koh OW Kwon 2004 Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula Ophthalmologica 218 193 201 10.1159/000076844 1:CAS:528:DC%2BD2cXjt12rs7k%3D 15103216 (Pubitemid 38596586)
16. A Otani M Sasahara Y Yodoi H Aikawa H Tamura A Tsujikawa N Yoshimura 2007 Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 7 14 10.1016/j.ajo.2007.03.014 1:CAS:528:DC%2BD2sXntF2kurY%3D 17467649 (Pubitemid 46963181)
17. S Matsushita T Naito M Takebayashi H Sato H Shiota 2008 The prognosis of cases with massive subretinal hemorrhage after photodynamic therapy J Med Invest 55 231 235 10.2152/jmi.55.231 18797136
18. Y Mitamura M Kubota-Taniai K Okada M Kitahashi T Baba S Mizunoya S Yamamoto 2009 Comparison of photodynamic therapy to transpupillary thermotherapy for polypoidal choroidal vasculopathy Eye 23 67 72 10.1038/sj.eye.6702996 1:CAS:528:DC%2BD1MXlvFGhtA%3D%3D 17901880
19. CM Eandi MD Ober KB Freund JS Slakter LA Yannuzzi 2007 Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization Retina 27 825 831 10.1097/IAE. 0b013e31804b3f70 17891004 (Pubitemid 47479375)
20. K Yamashiro A Tsujikawa A Nishida M Mandai Y Kurimoto 2008 Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy Jpn J Ophthalmol 52 457 462 10.1007/s10384-008-0582-2 19089566
21. D Tsuchiya T Yamamoto R Kawasaki H Yamashita 2009 Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions Retina 29 960 965 10.1097/IAE.0b013e3181a3b7c5 19491727
22. WK Lee PY Lee SK Lee 2008 Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence Jpn J Ophthalmol 52 108 115 10.1007/s10384-007-0501-y 18626733 (Pubitemid 351624396)
23. T Wakabayashi F Gomi M Sawa M Tsujikawa Y Tano 2008 Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy Br J Ophthalmol 92 936 940 10.1136/bjo.2007.132357 1:STN:280:DC%2BD1cvgvVCgtQ%3D%3D 18577645 (Pubitemid 351969674)
24. Y Hirami A Tsujikawa A Otani Y Yodoi H Aikawa M Mandai N Yoshimura 2007 Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy Retina 27 335 341 10.1097/01.iae.0000233647.78726.46 17460589 (Pubitemid 46398898)
25. Y Ojima A Tsujikawa A Otani Y Hirami H Aikawa N Yoshimura 2006 Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy Am J Ophthalmol 141 958 960 10.1016/j.ajo.2005.12.002 16678520
26. RF Spaide I Donsoff DL Lam LA Yannuzzi LM Jampol J Slakter J Sorenson KB Freund 2002 Treatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 529 535 10.1097/00006982-200210000-00001 12441716
27. RM Silva J Figueira ML Cachulo L Duarte dA Faria Jr JG Cunha-Vaz 2005 Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 973 979 10.1007/s00417-005-1139-4 1:CAS:528:DC%2BD2MXhtFart7fN 15864616 (Pubitemid 41631036)
28. M Wang IC Munch PW Hasler C Prunte M Larsen 2008 Central serous chorioretinopathy Acta Ophthalmol 86 126 145 10.1111/j.1600-0420.2007.00889.x 17662099
29. WM Chan DS Lam TY Lai BS Tam DT Liu CK Chan 2003 Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level Br J Ophthalmol 87 1453 1458 10.1136/bjo.87.12.1453 14660450 (Pubitemid 38010546)
30. WM Chan DS Lam TY Lai KS Yuen DT Liu CK Chan WQ Chen 2003 Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin Am J Ophthalmol 136 836 845 10.1016/S0002-9394(03) 00462-8 1:CAS:528:DC%2BD3sXosVyks7w%3D 14597034 (Pubitemid 37330026)
31. F Bandello G Virgili P Lanzetta A Pirracchio U Menchini 2001 ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy) J Fr Ophtalmol 24 448 451 1:STN:280:DC%2BD3Mzht1yjsA%3D%3D 11351219
32. BA Cooper MA Thomas 2000 Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy Am J Ophthalmol 130 187 191 10.1016/S0002-9394(00)00395-0 1:STN:280: DC%2BD3M%2FhsVensg%3D%3D 11004292
33. TY Lai WM Chan H Li RY Lai DT Liu DS Lam 2006 Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study Br J Ophthalmol 90 869 874 10.1136/bjo.2006.090282 1:STN:280:DC%2BD28zms1Wjuw%3D%3D 16597666 (Pubitemid 43973998)
34. WM Chan TY Lai RY Lai EW Tang DT Liu DS Lam 2008 Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study Retina 28 85 93 10.1097/IAE.0b013e318156777f 18185143
35. E Ergun M Tittl M Stur 2004 Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy Arch Ophthalmol 122 37 41 10.1001/archopht.122.1.37 1:CAS:528:DC%2BD2cXhtVWrsLY%3D 14718292 (Pubitemid 38063602)
36. MD Ober LA Yannuzzi DV Do RF Spaide NM Bressler LM Jampol A Angelilli CM Eandi AT Lyon 2005 Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy Ophthalmology 112 2088 2094 10.1016/j.ophtha.2005.06.026 16325707 (Pubitemid 41720985)
37. JW Moon HG Yu TW Kim HC Kim H Chung 2009 Prognostic factors related to photodynamic therapy for central serous chorioretinopathy Graefes Arch Clin Exp Ophthalmol 247 1315 1323 10.1007/s00417-009-1104-8 1:CAS:528:DC%2BD1MXhtVeqsbzI 19421764
38. E Ozmert F Batioglu 2009 Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy Ophthalmologica 223 263 268 10.1159/000210386 19339810
39. RM Tarantola JC Law FM Recchia P Sternberg Jr A Agarwal 2008 Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy Lasers Surg Med 40 671 675 10.1002/lsm.20720 19065564
40. PY Lee KS Kim WK Lee 2009 Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy Jpn J Ophthalmol 53 52 56 10.1007/s10384-008-0613-z 19184311
41. WM Chan TY Lai RY Lai DT Liu DS Lam 2008 Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial Ophthalmology 115 1756 1765 10.1016/j.ophtha.2008.04.014 18538401
42. MW Zhao P Zhou HX Xiao YS Lv CA Li GD Liu XX Li 2009 Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin Retina 29 1155 1161 10.1097/IAE.0b013e3181a6c028 19629018
43. M Gupta AD Singh PA Rundle IG Rennie 2004 Efficacy of photodynamic therapy in circumscribed choroidal haemangioma Eye 18 139 142 10.1038/sj.eye.6700597 1:CAS:528:DC%2BD2cXpsFSnsQ%3D%3D 14762404 (Pubitemid 38263462)
44. U Schmidt-Erfurth T Hasan 2000 Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration Surv Ophthalmol 45 195 214 10.1016/S0039-6257(00)00158-2 1:STN:280: DC%2BD3M7gslKjsA%3D%3D 11094244
45. U Schmidt-Erfurth W Bauman E Gragoudas TJ Flotte NA Michaud R Birngruber T Hasan 1994 Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin Ophthalmology 101 89 99 1:STN:280:DyaK2c7jsVCjsg%3D%3D 8302569 (Pubitemid 24044148)
46. AP Guagnini P De Potter L Levecq 2006 Photodynamic therapy of circumscribed choroidal hemangiomas J Fr Ophtalmol 29 1013 1017 10.1016/S0181-5512(06)73889-X 17114994
47. Y Xiong F Zhang 2007 Photodynamic therapy for circumscribed choroidal hemangioma Zhonghua Yan Ke Za Zhi 43 1085 1088 18331677
48. S Michels R Michels C Simader U Schmidt-Erfurth 2005 Verteporfin therapy for choroidal hemangioma: a long-term follow-up Retina 25 697 703 10.1097/00006982-200509000-00003 16141856 (Pubitemid 41254538)
49. FD Verbraak RO Schlingemann JE Keunen MD de Smet 2003 Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy Graefes Arch Clin Exp Ophthalmol 241 891 898 10.1007/s00417-003-0765-y 1:STN:280:DC%2BD3srmslGqug%3D%3D 14566571 (Pubitemid 37527048)
50. B Jurklies G Anastassiou S Ortmans A Schuler H Schilling U Schmidt-Erfurth N Bornfeld 2003 Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma Br J Ophthalmol 87 84 89 10.1136/bjo.87.1.84 1:STN:280:DC%2BD38jisFGnsA%3D%3D 12488269 (Pubitemid 36071785)
51. EA Huiskamp RP Muskens A Ballast JM Hooymans 2005 Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia Graefes Arch Clin Exp Ophthalmol 243 727 730 10.1007/s00417-004-1102-9 1:STN:280:DC%2BD2Mzkt1entg%3D%3D 15702328 (Pubitemid 40975502)
52. UM Schmidt-Erfurth S Michels C Kusserow B Jurklies AJ Augustin 2002 Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results Ophthalmology 109 2284 2294 10.1016/S0161-6420(02)01454-9 12466172 (Pubitemid 35417112)
53. A Boixadera J Garcia-Arumi V Martinez-Castillo JL Encinas J Elizalde G Blanco-Mateos J Caminal C Capeans F Armada A Navea JL Olea 2009 Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma Ophthalmology 116 100 105 10.1016/j.ophtha.2008.08.029 18973950
54. S Huang J Fabian T Murray W Shi 2009 Symptomatic circumscribed choroidal hemangioma undergoing PDT: VA outcomes Optom Vis Sci 86 286 289 10.1097/OPX.0b013e318196a724 19214133
55. G Porrini A Giovannini G Amato A Ioni M Pantanetti 2003 Photodynamic therapy of circumscribed choroidal hemangioma Ophthalmology 110 674 680 10.1016/S0161-6420(02)01968-1 12689885 (Pubitemid 36520062)
56. M Sagong J Lee W Chang 2009 Application of intravitreal bevacizumab for circumscribed choroidal hemangioma Korean J Ophthalmol 23 127 131 10.3341/kjo.2009.23.2.127 19568366
57. R Anand 2003 Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome Am J Ophthalmol 136 758 760 10.1016/S0002-9394(03)00423-9 14516829 (Pubitemid 37153204)
58. JM Lee WH Nam HK Kim 2007 Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks Korean J Ophthalmol 21 142 145 10.3341/kjo.2007.21.3.142 17804918
59. U Menchini G Virgili U Introini F Bandello M Ambesi-Impiombato A Pece MB Parodi G Giacomelli B Capobianco M Varano R Brancato 2004 Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy Retina 24 763 771 10.1097/00006982-200410000-00013 15492632 (Pubitemid 39391769)
60. LJ Singerman G Hatem 1981 Laser treatment of choroidal neovascular membranes in angioid streaks Retina 1 75 83 10.1097/00006982-198101020-00001 1:STN:280:DyaL3s%2Fpt1Cksw%3D%3D 6184760
61. L Arias O Pujol M Rubio J Caminal 2006 Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks Graefes Arch Clin Exp Ophthalmol 244 753 757 10.1007/s00417-005-0131-3 1:CAS:528:DC%2BD28XmtVaksbY%3D 16228218 (Pubitemid 43923200)
62. AC Browning AK Chung F Ghanchi SP Harding M Musadiq SJ Talks YC Yang WM Amoaku 2005 Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series Ophthalmology 112 1227 1231 10.1016/j.ophtha.2005.02.011 15921757 (Pubitemid 40916929)
63. H Heimann F Gelisken J Wachtlin A Wehner M Volker MH Foerster KU Bartz-Schmidt 2005 Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks Graefes Arch Clin Exp Ophthalmol 243 1115 1123 10.1007/s00417-005-1193-y 1:CAS:528:DC%2BD2MXhtlCksrrK 15947939 (Pubitemid 43124162)
64. B Jurklies N Bornfeld H Schilling 2006 Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks-long-term effects Ophthalmic Res 38 209 217 10.1159/000093071 1:CAS:528:DC%2BD28XnvVGlurc%3D 16679809 (Pubitemid 44213981)
65. M Karacorlu S Karacorlu H Ozdemir C Mat 2002 Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks Am J Ophthalmol 134 360 366 10.1016/S0002-9394(02)01626-4 1:CAS:528: DC%2BD38Xms1Kgtbk%3D 12208247
66. S Shaikh AJ Ruby GA Williams 2003 Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks Am J Ophthalmol 135 1 6 10.1016/S0002-9394(02)01835-4 1:CAS:528:DC%2BD38XpslSlurk%3D 12504689 (Pubitemid 36020416)
67. IC Kuo ET Cunningham Jr 2000 Ocular neovascularization in patients with uveitis Int Ophthalmol Clin 40 111 126 10.1097/00004397-200004000-00009 1:STN:280:DC%2BD3c3ltFymtA%3D%3D 10791260
68. J Brown Jr JC Folk CV Reddy AE Kimura 1996 Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome Ophthalmology 103 1100 1105 8684800
69. AM Mansour F Mackensen JF Arevalo F Ziemssen P Mahendradas A Mehio-Sibai N Hrisomalos TY Lai D Dodwell WM Chan T Ness AS Banker SA Pai MH Berrocal R Tohme A Heiligenhaus ZF Bashshur M Khairallah KM Salem FN Hrisomalos MH Wood W Heriot A Adan A Kumar L Lim A Hall M Becker 2008 Intravitreal bevacizumab in inflammatory ocular neovascularization Am J Ophthalmol 146 410 416 10.1016/j.ajo.2008.05.024 1:CAS:528:DC%2BD1cXhtVagtbfJ 18619571
70. HF Fine I Zhitomirsky KB Freund GR Barile BL Shirkey CM Samson LA Yannuzzi 2009 Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis Retina 29 8 12 10.1097/IAE. 0b013e318187aff9 18784620
71. TH Tran C Fardeau C Terrada DL Ducos B Bodaghi P Lehoang 2008 Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis Graefes Arch Clin Exp Ophthalmol 246 1685 1692 10.1007/s00417-008-0906-4 1:CAS:528:DC%2BD1cXhtlart7bN 18682970
72. A Adan C Mateo R Navarro E Bitrian RP Casaroli-Marano 2007 Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization Retina 27 1180 1186 10.1097/IAE.0b013e31815e9834 18046222 (Pubitemid 350211522)
73. WM Chan TY Lai DT Liu DS Lam 2007 Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin Am J Ophthalmol 143 977 983 10.1016/j.ajo.2007.02.039 1:CAS:528:DC%2BD2sXlvVaktbc%3D 17459318 (Pubitemid 46764660)
74. RM Coco CF de Souza MR Sanabria 2007 Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy Ocul Immunol Inflamm 15 27 29 10.1080/09273940601174020 17365803 (Pubitemid 46328436)
75. L Postelmans B Pasteels P Coquelet L Caspers C Verougstraete A Leys M Wirix M Mauget-Faysse M Quanranta B Snyers E Smets 2005 Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like) Ocul Immunol Inflamm 13 361 366 10.1080/09273940590951124 1:CAS:528: DC%2BD2MXhtV2gsLnK 16419421 (Pubitemid 41702759)
76. C Gerth G Spital A Lommatzsch A Heiligenhaus D Pauleikhoff 2006 Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis Eur J Ophthalmol 16 111 118 1:STN:280:DC%2BD287gvVGntA%3D%3D 16496254
77. JI Lim CJ Flaxel L LaBree 2006 Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease Ann Acad Med Singapore 35 198 202 16625270
78. M Mauget-Faysse G Mimoun JM Ruiz-Moreno M Quaranta-El Maftouhi JJ De Laey L Postelmans G Soubrane M Defauchy A Leys 2006 Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis Retina 26 396 403 10.1097/00006982-200604000-00003 16603957 (Pubitemid 44197630)
79. MB Parodi P Iacono S Spasse G Ravalico 2006 Photodynamic therapy for juxtafoveal choroidal neovascularization associated with multifocal choroiditis Am J Ophthalmol 141 123 128 10.1016/j.ajo.2005.07.045 16386985 (Pubitemid 43016181)
80. RF Spaide KB Freund J Slakter J Sorenson LA Yannuzzi Y Fisher 2002 Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy Retina 22 545 549 10.1097/00006982-200210000-00003 12441718
81. J Wachtlin H Heimann T Behme MH Foerster 2003 Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases Graefes Arch Clin Exp Ophthalmol 241 899 906 10.1007/s00417-003-0734-5 1:CAS:528:DC%2BD3sXpsVKru7c%3D 14556077 (Pubitemid 37527049)
82. MB Parodi CL Di P Lanzetta A Polito F Bandello G Ravalico 2004 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis Am J Ophthalmol 138 263 269 10.1016/j.ajo.2004.03.029 1:CAS:528:DC%2BD2cXmt1KltLo%3D 15289136 (Pubitemid 39037431)
83. A Hogan U Behan DJ Kilmartin 2005 Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation Br J Ophthalmol 89 1109 1111 10.1136/bjo.2004.063024 1:STN:280:DC%2BD2MvksFWntQ%3D%3D 16113360 (Pubitemid 41224455)
84. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1329 1345
85. L Postelmans B Pasteels P Coquelet H El Ouardighi C Verougstraete U Schmidt-Erfurth 2004 Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females Am J Ophthalmol 138 803 808 10.1016/j.ajo.2004.06.033 15531316 (Pubitemid 39452928)
86. J Wachtlin T Behme H Heimann U Kellner MH Foerster 2003 Concentric retinal pigment epithelium atrophy after a single photodynamic therapy Graefes Arch Clin Exp Ophthalmol 241 518 521 10.1007/s00417-003-0650-8 12734707 (Pubitemid 36833751)
87. MB Parodi S Da Pozzo G Ravalico 2007 Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia Acta Ophthalmol Scand 85 50 54 10.1111/j.1600-0420.2006.00738.x 17244210 (Pubitemid 46140156)
88. S Honda H Imai K Yamashiro Y Kurimoto N Kanamori-Matsui Y Kagotani Y Tamura H Yamamoto S Ohoto H Takagi M Uenishi A Negi 2009 Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan Ophthalmologica 223 333 338 10.1159/000221837 19478533
89. WM Chan DT Liu TY Lai H Li JP Tong DS Lam 2005 Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up Clin Experiment Ophthalmol 33 611 618 10.1111/j.1442-9071.2005.01105.x 16402954
90. N Hussain A Hussain S Natarajan 2005 Role of photodynamic therapy in polypoidal choroidal vasculopathy Indian J Ophthalmol 53 101 104 10.4103/0301-4738.16172 15976464
91. M Mauget-Faysse M Quaranta-El Maftouhi ME De La A Leys 2006 Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy Eur J Ophthalmol 16 695 704 1:STN:280: DC%2BD28nis1Citw%3D%3D 17061220
92. T Ogino M Takeda H Imaizumi U Okushiba 2007 Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year Jpn J Ophthalmol 51 210 215 10.1007/s10384-007-0436-3 17554484 (Pubitemid 46889507)
93. M Quaranta M Mauget-Faysse G Coscas 2002 Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Am J Ophthalmol 134 277 280 10.1016/S0002-9394(02)01516-7 12140043 (Pubitemid 34831840)
94. K Sayanagi F Gomi M Sawa M Ohji Y Tano 2007 Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 245 1569 1571 10.1007/s00417-007-0582-9 17437122 (Pubitemid 47423340)
95. SY Lee JG Kim SG Joe H Chung YH Yoon 2008 The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy Korean J Ophthalmol 22 92 99 10.3341/kjo.2008.22.2.92 18612226
96. AD Singh PK Kaiser JE Sears M Gupta PA Rundle IG Rennie 2004 Photodynamic therapy of circumscribed choroidal haemangioma Br J Ophthalmol 88 1414 1418 10.1136/bjo.2004.044396 1:STN:280:DC%2BD2crhslKqsw%3D%3D 15489484 (Pubitemid 39424721)
97. IM Landau B Steen S Seregard 2002 Photodynamic therapy for circumscribed choroidal haemangioma Acta Ophthalmol Scand 80 531 536 10.1034/j.1600-0420.2002. 800513.x 12390166 (Pubitemid 35243859)
98. ID Ladas I Georgalas AA Rouvas S Gotsis DA Karagiannis M Moschos 2005 Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment Eur J Ophthalmol 15 69 73 1:STN:280:DC%2BD2M7itVOlsw%3D%3D 15751242
99. WM Chan TY Lai TT Lau VY Lee DT Liu DS Lam 2008 Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series Retina 28 71 80 10.1097/IAE.0b013e31815e9339 18185141